Healthcare organizations have been increasingly adopting digital communication channels like email and text messaging. These channels offer convenience and flexibility for both healthcare providers and patients. When used judiciously, they can help improve the…
Continue Reading
NHS England is letting a contract worth £4.3 million to “enhance cyber risk visibility, assurance and resilience” throughout the NHS supply chain.An invitation to tender, published by NHSE on 20 June 2024, said the…
Continue Reading
Introduction
iCAD, Inc., a global leader in AI-powered cancer detection solutions, is set to showcase groundbreaking research at the Society for Imaging Informatics in Medicine (SIIM) Annual Meeting 2024. The focus will be on the…
The White House this past week announced its plans to ban new sales of antivirus software from Kaspersky Lab, after years of pushback against the Russia-based company, and fears that its tools themselves pose…
Continue Reading
While the research spotlighted the healthcare sector’s cybersecurity progress – earning it a “better than expected” B+ security rating for the first half of 2024, weaknesses in application and endpoint security present significant supply…
Continue Reading
Australia has one of the world’s highest levels of ultraviolet radiation, a proven carcinogen that causes skin care and eye diseases. UV damage is said to accumulate from childhood, and the risk of developing…
Continue Reading
A new international research led by Nanyang Technological University Singapore set out to uncover insights into the perceptions of Asian medical professionals about the use of AI in healthcare.FINDINGS
The researchers surveyed 165 gastroenterologists and gastrointestinal surgeons…
What You Should Know:
– ColdVentures, a medical device innovator, has unveiled the ColdVest – a groundbreaking wearable technology designed to prevent heat stroke fatalities.
– The ColdVest is the first-of-its-kind, Class 1 FDA-approved portable emergency…
Continue Reading
The current prostate cancer (PCa) screen test, prostate-specific antigen (PSA), has a high sensitivity for PCa but low specificity for high-risk, clinically significant PCa (csPCa), resulting in overdiagnosis and overtreatment of non-csPCa. Early identification…
Continue Reading
Eileen Haggerty, Area VP, Product and Solutions Marketing, NETSCOUT
From diagnosis to prescription, each facet of healthcare delivery hinges on the reliability of digital infrastructure in assuring the patient-care experience. Technical issues can impact diagnostic…
Continue Reading
